Ibrutinib and TGR-1202 Combo Encouraging Relapsed Leukemia or Lymphoma - 101931

Spotlight
Video

Ibrutinib and TGR-1202 Combo Encouraging Relapsed Leukemia or Lymphoma

ASHReport has 256 videos Subscribe Here

Loading........
Description: Jennifer Brown, MD of Dana Farber, discusses a promising study that combines Ibrutinib with TGR-1202 and its results at the 58th ASH Annual Meeting in San Diego, CA.
Shared By : ASHReport
Posted on : 12/09/16
Added : 1 year ago



Recommended

Nothing found.

More From ASHReport

Nothing found.